Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis

被引:95
作者
Inglese, M [1 ]
Li, BSY [1 ]
Rusinek, H [1 ]
Babb, JS [1 ]
Grossman, RI [1 ]
Gonen, O [1 ]
机构
[1] NYU, Sch Med, Dept Radiol, New York, NY 10016 USA
关键词
brain atrophy; brain MR spectroscopy (MRS); metabolite quantification; multiple sclerosis (MS); proton MRS; relapsing-remitting MS;
D O I
10.1002/mrm.10481
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
It is well known that multiple sclerosis (MS) pathogenesis continues even during periods of clinical silence. To quantify the metabolic characteristics of this activity we compared the absolute levels of N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) in the normal-appearing white matter (NAWM) between relapsing-remitting (RR) MS patients and controls. Metabolite concentrations were obtained with 3D proton MR spectroscopy at 1.5 T in a 480 cm(3) volume-of-interest (VOI), centered on the corpus callosum of 11 MS patients and 9 matched controls. Gray/white-matter/cerebral-spinal-fluid (CSF) volumes were obtained from MRI segmentation. Patients' average VOI tissue volume (V-T), 410.8 +/- 24.0 cm(3), and metabolite levels, NAA = 6.33 +/- 0.70, Cr = 4.67 +/- 0.52, Cho = 1.40 +/- 0.17 mM, were different from the controls by -8%, -9%, +22% and +32%. The Cho level was the only single metric differentiating patients from controls at 100% specificity and >90% sensitivity. Diffusely elevated Cho and Cr probably reflect widespread microscopic inflammation, gliosis, or de- and remyelination in the NAWM. Both metabolites are potential prognostic indicators of current disease activity, preceding NAA decline and atrophy. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 20 条
[1]   HISTOLOGICAL, HISTOCHEMICAL AND BIOCHEMICAL-STUDY OF THE MACROSCOPICALLY NORMAL WHITE MATTER IN MULTIPLE-SCLEROSIS [J].
ALLEN, IV ;
MCKEOWN, SR .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1979, 41 (01) :81-91
[2]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, G ;
ANTEL, J .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) :154-159
[3]   QUANTITATION OF PROTON NMR-SPECTRA OF THE HUMAN BRAIN USING TISSUE WATER AS AN INTERNAL CONCENTRATION REFERENCE [J].
BARKER, PB ;
SOHER, BJ ;
BLACKBAND, SJ ;
CHATHAM, JC ;
MATHEWS, VP ;
BRYAN, RN .
NMR IN BIOMEDICINE, 1993, 6 (01) :89-94
[4]  
Bitsch A, 1999, AM J NEURORADIOL, V20, P1619
[6]   3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D chemical shift imaging [J].
Gonen, O ;
Murdoch, JB ;
Stoyanova, R ;
Goelman, G .
MAGNETIC RESONANCE IN MEDICINE, 1998, 39 (01) :34-40
[7]   Total brain N-acetylaspartate -: A new measure of disease load in MS [J].
Gonen, O ;
Catalaa, I ;
Babb, JS ;
Ge, Y ;
Mannon, LJ ;
Kolson, DL ;
Grossman, RI .
NEUROLOGY, 2000, 54 (01) :15-19
[8]  
Hauser S.L., 1994, HARRISONS PRINCIPLES, V1994, P2287
[9]   BIOCHEMICAL-ALTERATIONS IN MULTIPLE-SCLEROSIS LESIONS AND NORMAL-APPEARING WHITE-MATTER DETECTED BY IN-VIVO P-31 AND H-1 SPECTROSCOPIC IMAGING [J].
HUSTED, CA ;
GOODIN, DS ;
HUGG, JW ;
MAUDSLEY, AA ;
TSURUDA, JS ;
DEBIE, SH ;
FEIN, G ;
MATSON, GB ;
WEINER, MW .
ANNALS OF NEUROLOGY, 1994, 36 (02) :157-165
[10]   Segmentation analysis in functional MRI: Activation sensitivity and gray-matter specificity of RARE and FLASH [J].
Hutchinson, M ;
Rusinek, H ;
Nenov, VI ;
Feinberg, DA ;
Johnson, G .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (02) :361-364